Email updates

Keep up to date with the latest news and content from CCS and BioMed Central.

Open Access Review

Atypical IκB proteins – nuclear modulators of NF-κB signaling

Marc Schuster12, Michaela Annemann12, Carlos Plaza-Sirvent12 and Ingo Schmitz12*

Author Affiliations

1 Systems-oriented Immunology and Inflammation Research, Helmholtz Center for Infection Research, Braunschweig, 38124, Germany

2 Institute for Molecular and Clinical Immunology, Otto-von-Guericke University, Magdeburg, 39120, Germany

For all author emails, please log on.

Cell Communication and Signaling 2013, 11:23  doi:10.1186/1478-811X-11-23

Published: 11 April 2013

Abstract

Nuclear factor κB (NF-κB) controls a multitude of physiological processes such as cell differentiation, cytokine expression, survival and proliferation. Since NF-κB governs embryogenesis, tissue homeostasis and the functions of innate and adaptive immune cells it represents one of the most important and versatile signaling networks known. Its activity is regulated via the inhibitors of NF-κB signaling, the IκB proteins. Classical IκBs, like the prototypical protein IκBα, sequester NF-κB transcription factors in the cytoplasm by masking of their nuclear localization signals (NLS). Thus, binding of NF-κB to the DNA is inhibited. The accessibility of the NLS is controlled via the degradation of IκBα. Phosphorylation of the conserved serine residues 32 and 36 leads to polyubiquitination and subsequent proteasomal degradation. This process marks the central event of canonical NF-κB activation. Once their NLS is accessible, NF-κB transcription factors translocate into the nucleus, bind to the DNA and regulate the transcription of their respective target genes. Several studies described a distinct group of atypical IκB proteins, referred to as the BCL-3 subfamily. Those atypical IκBs show entirely different sub-cellular localizations, activation kinetics and an unexpected functional diversity. First of all, their interaction with NF-κB transcription factors takes place in the nucleus in contrast to classical IκBs, whose binding to NF-κB predominantly occurs in the cytoplasm. Secondly, atypical IκBs are strongly induced after NF-κB activation, for example by LPS and IL-1β stimulation or triggering of B cell and T cell antigen receptors, but are not degraded in the first place like their conventional relatives. Finally, the interaction of atypical IκBs with DNA-associated NF-κB transcription factors can further enhance or diminish their transcriptional activity. Thus, they do not exclusively act as inhibitors of NF-κB activity. The capacity to modulate NF-κB transcription either positively or negatively, represents their most important and unique mechanistic difference to classical IκBs. Several reports revealed the importance of atypical IκB proteins for immune homeostasis and the severe consequences following their loss of function. This review summarizes insights into the physiological processes regulated by this protein class and the relevance of atypical IκB functioning.

Keywords:
NF-kappaB; Atypical IkappaB proteins; BCL-3; IkappaBNS; IkappaBzeta; IkappaBL; Nuclear NF-kappaB modulation; IkappaB eta; MAIL; NFkBID